NAD+, DHEA, Oxytocin, etc.

We can compound NAD+ in several forms including injectable solutions for IV or subcutaneous administration, sublingual troches or tablets, and nasal sprays. We also compound NAD+ precursors such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) in various oral formulations. All NAD+ preparations are created with attention to stability and potency, as these compounds can be sensitive to degradation.

We implement multiple quality assurance measures, including: using only pharmaceutical-grade ingredients with certificates of analysis; following strict compounding protocols with appropriate beyond-use dating; utilizing preservatives when necessary for product stability; proper pH adjustment for optimal stability; protection from light and temperature extremes during preparation and storage; and providing clear storage instructions for maintaining potency.

For optimal preparation, we need: complete patient information; detailed prescription specifications (compound type, concentration, delivery method); relevant allergies or sensitivities; quantity and directions for use; and any specific requirements regarding preservatives or other components. For complex cases or specialized protocols, information about the patient’s condition and treatment goals can help us recommend appropriate formulation options.

Yes, we can create combination formulations that include multiple specialty hormones or peptides when clinically appropriate and prescribed by a healthcare provider. These combinations may offer synergistic effects or improved patient compliance by reducing the number of separate medications. Our pharmacists can consult on potential compatibility issues and optimal formulation approaches for combination preparations.

Beyond-use dating for these specialized compounds varies based on several factors including the specific molecule, concentration, delivery form, preservative content, and storage conditions. NAD+ and many peptides are relatively unstable molecules that require careful handling and storage. We determine appropriate beyond-use dates based on stability data and USP guidelines for each specific formulation, typically ranging from 30-90 days depending on the preparation.

Yes, we offer several resources for healthcare providers interested in implementing specialty hormone and peptide therapies. These include one-on-one consultations with our compounding pharmacists, protocol guides for various applications, continuing education opportunities, and access to relevant literature and research. We’re committed to supporting your practice as you incorporate these advanced therapeutic options.